The planned instrument will help provide spatial information on both protein and RNA in tumor samples and will be powered by nCounter technology.
The custom-made software will also allow Twist's biopharmaceutical customers to access a proprietary G-protein coupled receptor target library.
Researchers discuss the need for antibody standards at a meeting, NPR reports.
The group this week published a set of initial guidelines for antibody validation meant as recommendations in advance of a larger meeting later this month.
The partners will collaborate on point-of-care tests for validating the identity and activity of biologics and biosimilars.
The move marks a step in the effort to improve antibody quality as the life science community becomes increasingly aware of the problem of faulty reagents.
The partners will continue to develop an integrated sequence and knowledge database to support Pierre Fabre's therapeutic antibody development efforts.
Abcam was encouraged to buy Firefly BioWorks by its customers, who are more frequently complementing their protein analysis work with miRNA studies.
Caprion, Asuragen, and the AIT Austrian Institute of Technology join the consortium launched in 2013 to develop blood-based tests for the early detection of cancers.
NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported a 4 percent increase in its third quarter revenues, as the company beat the consensus Wall Street estimate on the top line but missed on the bottom line.
Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.
Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.
Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.
In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.